Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ethyl 8-hydroxy-alpha-(2-propynylamino)-5-quinolinepropanoate is a synthetic small molecule with the chemical formula C17H18N2O3 and a molecular weight of approximately 298.34. It is classified as an experimental compound and has not been approved for clinical use or assigned any therapeutic indication. The compound contains a quinoline core substituted with hydroxy and propynylamino groups, as well as an ethyl ester moiety. While it is structurally related to bioactive quinolines such as 8-hydroxyquinoline (known for metal chelation and antimicrobial properties), there are no published data on its mechanism of action, pharmacological activity, or clinical development status[1][3][6][9]. It is primarily used in research settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ethyl 8-hydroxy-alpha-(2-propynylamino)-5-quinolinepropanoate.